Gene · 4855
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Androgen receptor signaling promotes Treg suppressive function during allergic airway inflammation. | J Clin Invest | 2022 | 35025767 | PubTator, text mining | PubMed |
| Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension. | Respir Res | 2022 | 35016680 | PubTator, text mining | PubMed |
| The clinical potential of articular cartilage-derived progenitor cells: a systematic review. | NPJ Regen Med | 2022 | 35013329 | PubTator, text mining | PubMed |
| Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine. | mBio | 2022 | 35012339 | PubTator, text mining | PubMed |
| GFI1 Cooperates with IKZF1/IKAROS to Activate Gene Expression in T-cell Acute Lymphoblastic Leukemia. | Mol Cancer Res | 2022 | 34980595 | PubTator, text mining | PubMed |
| Fostering a faster post-operative wound healing process with hyperbaric oxygen therapy in a rare case of squamous odontogenic tumor. | Int J Surg Case Rep | 2022 | 34968977 | PubTator, text mining | PubMed |
| Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants. | Kidney Int | 2022 | 34952098 | PubTator, text mining | PubMed |
| Identifying cancer pathway dysregulations using differential causal effects. | Bioinformatics | 2022 | 34927666 | PubTator, text mining | PubMed |
| A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC). | Clin Breast Cancer | 2022 | 34903452 | PubTator, text mining | PubMed |
| System analysis of VEGFA in renal cell carcinoma: The expression, prognosis, gene regulation network and regulation targets. | Int J Biol Markers | 2022 | 34870494 | PubTator, text mining | PubMed |
| The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions. | J Allergy Clin Immunol | 2022 | 34848210 | PubTator, text mining | PubMed |
| Mucosal tissue regulatory T cells are integral in balancing immunity and tolerance at portals of antigen entry. | Mucosal Immunol | 2022 | 34845322 | PubTator, text mining | PubMed |
| Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program. | Transl Oncol | 2022 | 34794033 | PubTator, text mining | PubMed |
| Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets. | Gastroenterology | 2022 | 34780722 | PubTator, text mining | PubMed |
| Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma. | Cancer Sci | 2022 | 34773335 | PubTator, text mining | PubMed |
| Unique functions for Notch4 in murine embryonic lymphangiogenesis. | Angiogenesis | 2022 | 34665379 | PubTator, text mining | PubMed |
| Mechano-regulated cell-cell signaling in the context of cardiovascular tissue engineering. | Biomech Model Mechanobiol | 2022 | 34613528 | PubTator, text mining | PubMed |
| NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy. | Leuk Lymphoma | 2022 | 34586000 | PubTator, text mining | PubMed |
| Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges. | Langenbecks Arch Surg | 2022 | 34505199 | PubTator, text mining | PubMed |
| Contradictory Effect of Notch1 and Notch2 on Phosphatase and Tensin Homolog and its Influence on Glioblastoma Angiogenesis. | Galen Med J | 2021 | 36643842 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4855/papers?page=44